# Design Therapeutics, Inc.: Form 8-K, filed Aug 3, 2026

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: 8-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 08:03 ET
- Period: 2026-08-03
- Accession: 0001193125-26-329570
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000119312526329570/dsgn-20260803.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000119312526329570/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000119312526329570/dsgn-20260803.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-329570. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
